Admera Health, a leading provider of next-generation sequencing (NGS) services, today announced it has become the first certified service provider (CSP) globally for the Takara Bio Shasta Single Cell System. This recognition immediately positions Admera Health at the forefront of the single-cell genomics industry, offering researchers unparalleled access to one of the most powerful and […]
continue reading
Research studies ranging from cancer genomics in underrepresented populations or plastic degradation in the Antarctic oceans now have expanded access to cutting-edge sequencing technology services. Admera Health, a leading provider of advanced genomics and bioinformatics services utilizing next-generation sequencing, announced it has been selected to receive AWS credits through Amazon Web Services‘ (AWS) Social Impact […]
continue readingAdmera Health, LLC, a leading provider of Next-Generation Sequencing services for researchers worldwide, today announced it has received re-accreditation from The Accreditation Committee of the College of American Pathologists (CAP). This significant achievement, following a rigorous on-site inspection of its South Plainfield, New Jersey laboratory, serves as a powerful testament to Admera Health’s unwavering dedication […]
continue reading